MedTrace Logo

Guideline-recommended Basic Parameter Adherence in Neurocritical Care Patients

NCT06367543 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 474

Last updated 2025-04-06

No results posted yet for this study

Summary

The aim of the planned study project is to assess the current situation regarding the treatment of patients with severe stroke at the neuro-critical care unit. Specifically, determination of whether the target parameters recommended in the guidelines for temperature, systolic blood pressure, mean arterial blood pressure, blood glucose, arterial oxygen partial pressure and arterial carbon dioxide partial pressure had to be maintained. From the planned data analysis, the need for the introduction of cerebrovascular bundles can be derived and planned.

Conditions

Interventions

DIAGNOSTIC_TEST

Time in therapeutic range of vital parameters

Treatment adherence on NICU to the following vital parameters: 1. Temperature (T\<37,5°C) (every 4 hours during the first 96 h after admission to neurocritical care unit) 2. systolic blood pressure ICD-10 (International Statistical Classification of Diseases 10th Revision) (I60, 161 \& 162): 100-140 mmHg ICD-10 (I63): 120-180 mmHg (every 4 hours during the first 96 h after admission to neurocritical care unit) 3. Mean arterial blood pressure (MAP: 60-90 mmHg) (every 4 hours during the first 96 h after admission to neurocritical care unit) 4. Arterial oxygen partial pressure (paO2: 75 - 100 mmHg) (every 4 hours during the first 96 h after admission to neurocritical care unit) 5. Arterial carbon dioxide partial pressure (paCO2: 35 - 45 mmHg). (every 4 hours during the first 96 h after admission to neurocritical care unit) 6. Blood glucose (BG: 80-180 mg/dL). (every 4 hours during the first 96 h after admission to neurocritical care unit)

Sponsors & Collaborators

  • University of Leipzig

    collaborator OTHER

  • University of Wuerzburg

    collaborator OTHER

  • Technical University of Munich

    collaborator OTHER

  • Heidelberg University

    collaborator OTHER

  • University of Cologne

    collaborator OTHER

  • University of Mannheim

    collaborator OTHER

  • University Hospital, Essen

    collaborator OTHER

  • University of Giessen

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06367543 on ClinicalTrials.gov